# Contineum Therapeutics, Inc.: Form DEF 14A, filed Apr 30, 2026

- Company: [Contineum Therapeutics, Inc.](/companies/ctnm.md) (CIK 1855175)
- Form: DEF 14A
- Filed: 2026-04-30
- Accepted by EDGAR: Apr 30, 2026, 16:08 ET
- Period: 2026-06-26
- Accession: 0001628280-26-028881
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1855175/000162828026028881/ctnm-20260430.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1855175/000162828026028881/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1855175/000162828026028881/ctnm-20260430.htm

Filed Apr 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-028881. Last ingested by Listed: Nov 4, 2026, 17:32 ET. No prices; not investment advice.